0000080424-26-000060
SEC filingP&G delivered solid top-line growth and strong cash generation in Q3 FY2026, though operating income growth remained modest. Innovation in developing markets offset competitive pressures in North America and Greater China, supporting margin expansion.
Gross profit rose to $10.5 billion from $10.1 billion in the prior year period, resulting in a gross margin of 49.5%. Management commentary indicates that productivity savings and lower commodity costs supported margins, though these benefits were partially offset by product mix dynamics and continued investment. Operating income remained relatively flat at $4.6 billion compared to the prior year, reflecting an operating margin of 21.5%. Net income increased to $3.9 billion, or $1.63 per diluted share, compared to $3.8 billion, or $1.54 per diluted share, in the prior year.
Operational signals highlight specific challenges in key markets, with Family Care net sales increasing mid-single digits due to prior year inventory reductions, though partially offset by lower pricing from merchandising investments. Management noted that the company expects to incur over half of the costs under its current restructuring plan by the end of fiscal 2026, with the remainder in fiscal 2027, indicating a continued focus on productivity and structural optimization.